Cargando…

Effect of Scopolamine Butylbromide on Clozapine-induced Hypersalivation in Schizophrenic Patients: A Case Series

Clozapine has been demonstrated to be useful for treating refractory schizophrenia. However, hypersalivation occurs in 31.0–97.4% of the patients treated with clozapine. Accordingly, some patients who are disturbed by their hypersalivation refuse to continue with clozapine treatment. This study inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeuchi, Ippei, Suzuki, Tatsuyo, Kishi, Taro, Kanamori, Daisuke, Hanya, Manako, Uno, Junji, Fujita, Kiyoshi, Kamei, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423163/ https://www.ncbi.nlm.nih.gov/pubmed/25912544 http://dx.doi.org/10.9758/cpn.2015.13.1.109

Ejemplares similares

Effect of Adenine on Clozapine-induced Neutropenia in Patients with Schizophrenia: A Preliminary Study
por: Takeuchi, Ippei, et al.
Publicado: (2015)

A Questionnaire-based Study of the Views of Schizophrenia Patients and Psychiatric Healthcare Professionals in Japan about the Side Effects of Clozapine
por: Takeuchi, Ippei, et al.
Publicado: (2016)

Usefulness of a psychomotor function test as a cognitive function scale for patients with schizophrenia: A pilot study
por: Kamei, Hiroyuki, et al.
Publicado: (2021)

Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with Schizophrenia
por: Hatano, Masakazu, et al.
Publicado: (2017)

Neonatal treatment with scopolamine butylbromide prevents metabolic dysfunction in male rats
por: Malta, Ananda, et al.
Publicado: (2016)

Clozapine: Drowsiness with markedly increased hypersalivation and myoclonus secondary to clozapine toxicity: case report
Publicado: (2021)

Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome
por: Iihara, Hirotoshi, et al.
Publicado: (2018)

The Problem Schizophrenic : Clozapine or ECT?
por: Andrade, C.
Publicado: (1996)

A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH)
por: Livermore, Cecilia, et al.
Publicado: (2022)

Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): a feasibility study
por: Qurashi, Inti, et al.
Publicado: (2019)

Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer
por: Peng, Xingang, et al.
Publicado: (2015)

Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial
por: Fujii, Tomoo, et al.
Publicado: (2021)

Acceptance of the Deltoid Muscle Injection of Aripiprazole Long-acting Injectable in the Patients with Schizophrenia
por: Kamei, Hiroyuki, et al.
Publicado: (2020)

Efficacy of sofpironium bromide gel on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: double-blind, controlled crossover study
por: Amano, Yuhei, et al.
Publicado: (2023)

AN OPEN CLINICAL TRIAL WITH CLOZAPINE IN TREATMENT-RESISTANT SCHIZOPHRENICS
por: Agarwal, A.K., et al.
Publicado: (1997)

Satisfaction Survey on Antipsychotic Formulations by Schizophrenia Patients in Japan
por: Hatano, Masakazu, et al.
Publicado: (2021)

Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study
por: Qurashi, Inti, et al.
Publicado: (2016)

Hyoscine butylbromide induced psychosis: A case report
por: Lageju, Nimesh, et al.
Publicado: (2022)

Effects of communication skill training (CST) based on SPIKES for insurance-covered pharmacy pharmacists to interact with simulated cancer patients
por: Hanya, Manako, et al.
Publicado: (2017)

Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series
por: Kamei, Hiroyuki, et al.
Publicado: (2020)

Hyoscine-N-butylbromide induced ventricular tachycardia during ERCP
por: Ozaslan, Ersan, et al.
Publicado: (2014)

Botulinum toxin treatment for hypersalivation in anti‐NMDA receptor encephalitis
por: Jun, Jin‐Sun, et al.
Publicado: (2017)

Cessation of clozapine-induced severe hypersalivation along with improvement of residual persistent auditory hallucinations by tDCS in a patient of chronic schizophrenia - A case report
por: Astha,, et al.
Publicado: (2022)

The Treatment of Hypersalivation in Rett Syndrome with Botulinum Toxin: Efficacy and Clinical Implications
por: Bernardo, Pia, et al.
Publicado: (2019)

The effect of hyoscine n- butylbromide on labor progress: A systematic review
por: Mohaghegh, Zaynab, et al.
Publicado: (2020)

Clozapine Use Presenting with Pseudopheochromocytoma in a Schizophrenic Patient: A Case Report
por: Sara, Jaskanwal, et al.
Publicado: (2013)

Concomitant Use of Topiramate Inducing Neutropenia in a Schizophrenic Male Stabilized on Clozapine
por: Sharma, Pravesh, et al.
Publicado: (2016)

Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
por: Hatano, Masakazu, et al.
Publicado: (2018)

Subjective assessment of brexpiprazole in patients with schizophrenia: a prospective observational study
por: Yokoi, Rina, et al.
Publicado: (2023)

Hyoscine butylbromide for colorectal polyp detection: prospective, randomized, placebo-controlled trial
por: dos Santos, Carlos Eduardo Oliveira, et al.
Publicado: (2017)

Hypersalivation and coarse tremors as uncommon side effects of acamprosate: A case report
por: Bhandutia, D., et al.
Publicado: (2021)

Hiccups, Hypersalivation, Hallucinations in Parkinson’s Disease: New Insights, Mechanisms, Pathophysiology, and Management
por: Metta, Vinod, et al.
Publicado: (2023)

Ictal hypersalivation as a prominent symptom in a girl with insulo‐opercular epilepsy
por: Sun, Ke, et al.
Publicado: (2023)

Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study
por: Hatano, Masakazu, et al.
Publicado: (2023)

Clozapine Augments Delta, Theta, and Right Frontal EEG Alpha Power in Schizophrenic Patients
por: MacCrimmon, D., et al.
Publicado: (2012)

M138. THE STRUCTURAL AND FUNCTIONAL BRAIN IMPACT OF CLOZAPINE IN SCHIZOPHRENIC PATIENTS: REVIEW OF THE LITERATURE
por: Metivier, Lucie, et al.
Publicado: (2020)

Clozapine Response for Vocal Tics in Schizophrenic Patients: A Case Report With Literature Review
por: Begum, Gulshan, et al.
Publicado: (2021)

Ictal Hypersalivation and Salivary Gland Enlargement in a Patient With Acquired Frontal Lobe Epilepsy
por: Mader, Edward C, et al.
Publicado: (2021)

Antiperistaltic effect and safety of l-menthol for esophagogastroduodenoscopy in the elderly with contraindication to hyoscine-N-butylbromide
por: Yang, Tsung-Chieh, et al.
Publicado: (2022)

Brexpiprazole augmentation in a clozapine-resistant young schizophrenic patient: a successful case report.
por: Martiadis, V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sjepsesv9j3lhsspf25pp6nqje